Crown Bioscience Brings Top Scientists Together
News Oct 03, 2015
Crown Bioscience hosted a symposium earlier this month for some of the industry’s leading experts to discuss the latest scientific discoveries in translational oncology.
“Some of the foremost researchers in this field shared information about immuno-oncology therapies and their impact on translational oncology,” said Christopher Murriel, Ph.D., who chaired the event in San Diego. A senior scientist in department of cancer biology at OncoMed Pharmaceuticals, he spoke at the symposium about the use of patient-derived and murine tumor models to predict impacts on cancer stem cells and anti-tumor immunity.
“Translational research, particularly in oncology, holds tremendous potential toward therapeutic drug development and clinical advancement - and the scientists at this symposium presented exciting research that demonstrates how much opportunity exists,” said Murriel. Using clinically-relevant models, Crown Bioscience helps researchers make the best decisions to speed the optimum drug candidates to clinical development.
“We’re pleased to share our expertise and sponsor this forum for scientists and clinicians to discuss the merits of current and future approaches,” said Jean-Pierre Wery, Ph.D., resident of Crown Bioscience. “Our goal is to spur change by helping the industry translate preclinical research into medicines to improve the health and quality of life of patients.”
Henry Li, Ph.D., vice president of translational oncology at Crown Bioscience, discussed the molecular pathway of patient-derived xenograft diseases. Tommy Broudy, Ph.D., general manager and chief scientific officer at Crown Bioscience San Diego, spoke about the adoption of clinically relevant models in oncology therapeutics.
Chief scientists from Decoy Biosystems, Tragara Pharmaceuticals, ImmunGene, Regulus Therapeutics, Ignyta and Pfizer also spoke.
Crown Bioscience will host another symposium Nov. 4 in Boston; details will soon be provided.
Discovery Advances Efforts to Prevent Spread of CancerNews
Newly identified gene targets could be key to preventing the spread of cancer, new University of Alberta research has shown.
Higher BMI is Associated with a Lower Risk of Breast Cancer Before MenopauseNews
Having a higher body mass index (BMI) at a younger age is associated with a decreased risk of developing breast cancer before the menopause, major new research funded by Breast Cancer Now and other collaborators has found.READ MORE
Miniature Testing of Drug Pairs on Tumor BiopsiesNews
Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device. The research marks the latest advancement in the field of personalised medicine. Using a microfluidic device that fits in the palm of your hand, scientists screened over 1100 treatment conditions on patient tumour cells. In the future, such tests could be used to inform clinicians on safe and effective combinations of cancer treatments.READ MORE